Matches in Wikidata for { <http://www.wikidata.org/entity/Q61918482> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q61918482 description "assaig clínic" @default.
- Q61918482 description "clinical trial" @default.
- Q61918482 description "clinical trial" @default.
- Q61918482 description "clinical trial" @default.
- Q61918482 description "clinical trial" @default.
- Q61918482 description "ensaio clínico" @default.
- Q61918482 description "ensayo clínico" @default.
- Q61918482 description "ensayu clínicu" @default.
- Q61918482 description "essai clinique" @default.
- Q61918482 description "klinisch onderzoek" @default.
- Q61918482 description "клінічне випробування" @default.
- Q61918482 description "կլինիկական փորձարկում" @default.
- Q61918482 name "Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)" @default.
- Q61918482 type Item @default.
- Q61918482 label "Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)" @default.
- Q61918482 prefLabel "Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)" @default.
- Q61918482 P1050 Q61918482-00C18B4F-EBA1-4B8B-97B2-2F71B9951E41 @default.
- Q61918482 P1132 Q61918482-033D796C-FF56-464C-B15E-90464C673374 @default.
- Q61918482 P1476 Q61918482-2942A22D-4A4F-464E-995F-D2C5F660255E @default.
- Q61918482 P2899 Q61918482-DA07DF09-61A2-40CF-9891-B424C86C062B @default.
- Q61918482 P3098 Q61918482-0EC228FD-D238-49DC-B02E-43F66F456C84 @default.
- Q61918482 P31 Q61918482-AEE3E876-2A0E-467A-A926-2FA6ED06CDEB @default.
- Q61918482 P4135 Q61918482-05B2EF98-B6C7-4D36-9CD4-12DEF21879A9 @default.
- Q61918482 P4844 Q61918482-57E7FC1C-8FD8-4887-90A3-1053056761A7 @default.
- Q61918482 P4844 Q61918482-6E7162CB-BBD6-40DB-8428-DEBC19CBA30F @default.
- Q61918482 P580 Q61918482-57ED656B-336D-47F2-8755-DAF207DC27C5 @default.
- Q61918482 P582 Q61918482-FE9326F3-65AC-4786-980B-21CA305246B0 @default.
- Q61918482 P6099 Q61918482-99B3C864-D43E-4C61-B011-23A282B54637 @default.
- Q61918482 P8363 Q61918482-F1629DD6-B084-47EE-8C85-D49C9ECD05BD @default.
- Q61918482 P859 Q61918482-E15BCF7E-CCF9-4656-8C54-9130FFEB89D8 @default.
- Q61918482 P1050 Q12206 @default.
- Q61918482 P1132 "+796" @default.
- Q61918482 P1476 "A Multicenter, Randomized, Double-Blind, Placebo Controlled 36 Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant in Patients With Type 2 Diabetes" @default.
- Q61918482 P2899 "+18" @default.
- Q61918482 P3098 "NCT00485758" @default.
- Q61918482 P31 Q30612 @default.
- Q61918482 P4135 "+80" @default.
- Q61918482 P4844 Q134658 @default.
- Q61918482 P4844 Q192423 @default.
- Q61918482 P580 "2007-07-01T00:00:00Z" @default.
- Q61918482 P582 "2008-08-01T00:00:00Z" @default.
- Q61918482 P6099 Q42824827 @default.
- Q61918482 P8363 Q78089383 @default.
- Q61918482 P859 Q58219685 @default.